Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations-Reference-Cited by-同舟云学术

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations

Published:2018-08-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Eleje George U¹,Eke Ahizechukwu C²,Ezebialu Ifeanyichukwu U³,Ikechebelu Joseph I⁴,Ugwu Emmanuel O⁵,Okonkwo Onyinye O⁶

Affiliation:

1. Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University, Nnewi Campus; Effective Care Research Unit, Department of Obstetrics and Gynaecology; PMB 5001, Nnewi Anambra State Nigeria

2. Johns Hopkins University School of Medicine; Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics; 600 N Wolfe Street Phipps 228 Baltimore Maryland USA 21287-1228

3. Faculty of Clinical medicine, College of Medicine, Anambra State University Amaku; Department of Obstetrics and Gynaecology; Awka Nigeria

4. Nnamdi Azikiwe University Teaching Hospital; Department of Obstetrics/Gynaecology; Nnewi Nigeria

5. University of Nigeria Enugu Campus/University of Nigeria Teaching Hospital Ituko-Ozalla; Obstetrics and Gynaecology; Enugu Nigeria 400001

6. Tabitha Medical Centre; Department of Pathology; Abuja Nigeria 400001

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012464.pub2/epdf/full

Reference161 articles.

1. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study;Domchek;Lancet Oncology,2006

2. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA,2010

3. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction;Heemskerk-Gerritsen;Journal of the National Cancer Institute,2015

4. Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral;Ingham;Breast Cancer Research and Treatment,2013

5. Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers;Kotsopoulos;Journal of the National Cancer Institute,2017

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

2. Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy;Obstetrics & Gynecology Science;2024-07-15

3. Estrategias de pesquisa en mujeres de alto riesgo para cáncer de mama: revisión de la literatura;Revista de Senología y Patología Mamaria;2024-07

4. Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy;Familial Cancer;2024-06-21

5. Implications of FDA’s marketing authorization of hereditary cancer testing;Journal of Cancer Policy;2024-06